Medicalsystem Biotechnology Co.,Ltd.’s Net Profit Rose 14.3% in First Half of 2022

Medicalsystem Biotechnology Co.,Ltd. (美康生物科技股份有限公司) (300439.SZ) reported a net profit of 143.9 million yuan in the first half of 2022, up 14.3% year-on-year.
Meanwhile, the company posted 1.3 billion yuan in revenue, up 15.1% year-on-year.
At the end of the reporting period, it had 3.6 billion yuan in total assets and 1.2 billion yuan in total liabilities, with a liability-to-asset ratio of 32.1%.
- PODCAST
- MOST POPULAR